ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma

Is it time to move away from short-acting beta-agonists in asthma management?

(2019) Matthew J. Martin et al.   EUROPEAN RESPIRATORY JOURNAL

Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma

(2019) Richard Beasley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

(2019) Jo Hardy et al.   LANCET

Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma

(2018) Diana M. Sobieraj et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

After asthma: redefining airways diseases

(2018) Ian D Pavord et al.   LANCET

Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

(2018) Paul M. O’Byrne et al.   NEW ENGLAND JOURNAL OF MEDICINE

As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma

(2018) Eric D. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity

(2018) Richard Beasley et al.   EUROPEAN RESPIRATORY JOURNAL

The paradoxes of asthma management: time for a new approach?

(2017) Paul M. O'Byrne et al.   EUROPEAN RESPIRATORY JOURNAL

Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative

(2017) John D. Blakey et al.   Journal of Allergy and Clinical Immunology-In Practice

Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model

(2016) Rik J B Loymans et al.   THORAX

Predictors of Severe Exacerbations, Poor Asthma Control, and β-Agonist Overuse for Patients with Asthma

(2014) Mitesh Patel et al.   Journal of Allergy and Clinical Immunology-In Practice

Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial

(2013) Mitesh Patel et al.   Lancet Respiratory Medicine

Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial

(2013) Alberto Papi et al.   Lancet Respiratory Medicine

Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: Phase III study results

(2012) TITO ATIENZA et al.   RESPIROLOGY

Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy

(2010) M. Aubier et al.   EUROPEAN RESPIRATORY JOURNAL

Budesonide/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials

(2010) S. J. Edwards et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Rescue Treatment in Asthma

(2009) Alberto Papi et al.   CHEST

A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma

(2008) B. Ställberg et al.   RESPIRATORY MEDICINE